【24h】

Radiation therapy in the treatment of desmoid tumours reduces surgical indications.

机译:放射疗法治疗类胶质瘤减少了手术指征。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: While several modalities have been proposed for the treatment of desmoid tumour/aggressive fibromatosis, high local recurrence rates have been reported. We present a retrospective study of including patients treated with radiation therapy, some of them in combination with surgical resection. PATIENTS AND METHODS: Thirty-four consecutive patients were included (mean age 40+/-16 years, 9 male). Complete follow-up was available in 31 patients (51+/-36 months). Seventeen patients (50%) were treated with radiation therapy alone, 17 patients with radiation therapy and surgery. Radiation therapy (external beam) was applied in most cases to a total dose of 50.4 Gy in 28 fractions. The lesion was located in the upper extremity in 11 patients, in the lower extremity in 14 cases and on the trunk in 9 cases. RESULTS: Overall recurrence/progression free survival was 88.5% at 5 years and 77.5% at 10 years. Recurrence free survival of the subset of patients undergoing combined treatment with radiation therapy and surgical resection was 83.6% at 5 years and 10 years. In patients who did not receive surgery but only radiation therapy, MRI showed a complete response in 20%, a partial response in 20%, and stable disease in 53% of cases. In this subset, two-third of patient had a metabolic response to radiotherapy (i.e. decrease uptake on the thallium-210 scan after radiotherapy compared to pre-therapy levels). CONCLUSION: Low recurrence rates can be achieved with the use of radiation therapy alone in selected cases. Patients with a metabolic response (decrease) to radiotherapy may be treated with a non-surgical approach. Surgery might be considered in patients with a poor metabolic response to radiotherapy.
机译:背景:尽管已经提出了几种治疗皮肤样瘤/侵袭性纤维瘤病的方法,但据报道局部复发率很高。我们提供了一项回顾性研究,其中包括接受放射治疗的患者,其中一些患者接受了手术切除。患者与方法:纳入34例连续患者(平均年龄40 +/- 16岁,男9例)。 31名患者(51 +/- 36个月)可以进行完整的随访。仅接受放射治疗的患者为17例(50%),接受放射治疗和手术的患者为17例。在大多数情况下,放射治疗(外部射线)的总剂量为50.4 Gy,分为28个部分。病变位于上肢11例,下肢14例,躯干9例。结果:5年总复发/无进展生存率为10年,无复发生存率为77.5%。在5年和10年时,接受放射治疗和手术切除的联合治疗的患者亚群的无复发生存率为83.6%。在没有接受手术而仅接受放射治疗的患者中,MRI显示完全缓解率为20%,部分缓解为20%,疾病稳定的患者为53%。在这一亚组中,三分之二的患者对放疗有代谢反应(即与治疗前水平相比,放疗后decrease 210扫描的摄取减少)。结论:在某些情况下,仅使用放射治疗可降低复发率。对放疗有代谢反应(减少)的患者可以采用非手术方法治疗。对放疗的新陈代谢反应较差的患者可考虑手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号